Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

05/27 19:08   Azerbaijani president: Baku will work for restoration of country's territorial integrity
 
05/27 19:08   Still room for Russian gas in Europe after Trans Adriatic Pipeline built - Novak
 
05/27 19:06   Transnefteproduct's Nikolai Gorban named to head CPC
 
05/27 19:03   Greek President: Putin's visit to have "exceptionally important implications" (Part 2)
 
05/27 19:00   German foreign minister: Anti-Russian sanctions can be lessened if there is progress on Minsk Agreements
 
05/27 18:58   Poroshenko thanks Obama, Biden for contribution in Savchenko release
 
05/27 18:54   Russian Defense Ministry suspects U.S. testing missiles banned by INF Treaty under guise of missile defense tests (Part 2)
 
05/27 18:53   Poroshenko calls for tougher sanctions against Russia in conversation with Biden
 
05/27 18:52   Russia not bothered by Klimkin's announcement of "Savchenko list" extension - Klintsevich
 
05/27 18:46   Sollers recommends 2015 dividend waiver
 




 

Interfax.com  |  Interfax news  |  FAS green-lights AFK Sistema bid to buy 100% of...


News headlines


November 12, 2012 15:08

FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)

MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.

The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.

The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.

Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.

The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.

AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.

The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.

According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.

Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.

Cf

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

May 27, 2016
 
18:54
Russian Defense Ministry suspects U.S. testing missiles banned by INF Treaty under guise of missile defense tests (Part 2)
 
18:53
Poroshenko calls for tougher sanctions against Russia in conversation with Biden
 
18:52
Russia not bothered by Klimkin's announcement of "Savchenko list" extension - Klintsevich
 
18:46
Sollers recommends 2015 dividend waiver
 
18:46
No plans to expand list of embargoed food products - Tkachev
 
18:43
SOLLERS BOARD RECOMMENDS 2015 DIVIDEND WAIVER - COMPANY
 
18:41
Sberbank not considering participation in RusHydro recapitalization (Part 2)
 
18:40
Observers from CIS, SCO invited to Russia for parliamentary elections, participation of OSCE's ODIHR mission possible
 
18:40
NO EXPANSION OF EMBARGOED FOOD PRODUCTS LIST PLANNED; ONLY EXTENSION OF EFFECTIVE DATE BEING DISCUSSED - TKACHEV
 
18:39
Kyrgyz president urges Armed Forces to be ready to resist any 'dark forces'
 
18:39
VTB boosts stake in Enel Russia to 7.69% (Part 2)
 
18:37
 
18:34
Forty percent of Russians who know about Savchenko's verdict approve of her exchange for Russian citizens - poll
 
18:30
Greek President: Putin's visit to have "exceptionally important implications"
 
 more headlines 



Interviews
 

.
U.S. Department of State Special Envoy and Coordinator for International Energy Affairs Amos Hochstein has given an interview to Interfax‘s special correspndent in the United States Ksenia Baygarova in which he speaks about why the United States has started to export oil and gas, how realistic the intention of oil producing countries to freeze oil production is, and how U.S. energy companies react to sanctions against Russia.

more
.
.
Newly appointed British Ambassador to Russia Laurie Bristow has given an interview to Interfax in which he speaks with about the current situation in British-Russian relations in the political, economic and cultural spheres, about LondonСs position on the crises in Syria and Ukraine and shares his opinion on the Yury Gagarin flight.

more
.
.
World Jewish Congress President Ronald Lauder has given an interview to Interfax in which he speaks about issues that he discussed at a meeting with Russian President Vladimir Putin, about how the inflow of immigrants has influenced the situation with anti-Semitism in Europe and about attempts to rewrite the WW II history.

more

 
  
 ©   1991—2016   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100